Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of other drugs on Obefazimod
3 evidence topics · 2 sources
Fluvoxamine, a CYP1A2 inhibitor: obefazimod exposure in healthy participants (Part B)
| Parameter | Day 1, obefazimod 50 mg alone | Day 11, obefazimod 50 mg with fluvoxamine 100 mg |
|---|---|---|
| Participants analyzed | “25” | “25” |
| Cmax, ng/mL, mean (SD) | “23.2(12.5)” | “33.4(19.0)” |
| AUC, h*ng/mL, mean (SD) | “55.2(25.7)” | “73.0(34.2)” |